Garware Fulflex has announced the successful completion of its acquisition of a 300,000-square-foot, fully automated medical products manufacturing facility in Jacksonville, Texas, marking a major milestone in the company’s global healthcare growth strategy and significantly expanding its manufacturing footprint in North America. The facility, located on a 30-acre campus, employs more than 250 people and produces a wide range of critical medical products used by healthcare providers and patients across North America and international markets. Its advanced, highly automated infrastructure includes state-of-the-art injection molding, blow molding, thermoforming, extrusion, assembly, and quality systems, further strengthening Garware Fulflex’s ability to partner with leading global healthcare companies.
The acquisition substantially enhances the company’s presence in the United States and reinforces its long-term strategy of building a leading global healthcare manufacturing platform. “This acquisition represents a defining milestone in our journey to build a globally respected healthcare manufacturing company,” said Diya Garware Ibanez, Chairperson of Garware Fulflex. “The Jacksonville facility brings exceptional people, world-class manufacturing capabilities, and an important presence in the world’s largest healthcare market. Most importantly, we are proud to welcome more than 250 talented employees to the Fulflex family. Together, we will continue delivering high-quality medical products while investing in innovation, operational excellence, and long-term growth.”
With the addition of the Jacksonville site, Garware Fulflex continues to strengthen its global manufacturing network, offering customers greater production capacity, enhanced technical expertise, improved supply chain resilience, and closer proximity to the North American healthcare market. The company expects the expanded footprint to support deeper collaboration with healthcare clients, faster response times, and the ability to scale innovative medical products that meet evolving clinical and patient needs.
